1. Home
  2. ZTS

ZTS

Zoetis Inc.

Logo Zoetis Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
-
.
-
-
-
-
.
-
-
%

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Founded: 1952 Country:
United States
United States
Employees: N/A City: PARSIPPANY
Market Cap: 74.6B IPO Year: 2013
Target Price: $226.57 AVG Volume (30 days): 2.9M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: 1.15% Dividend Payout Frequency: Quarterly
EPS: 5.07 EPS Growth: 12.92
52 Week Low/High: $148.48 - $201.92 Next Earning Date: 05-02-2024
Revenue: $8,544,000,000 Revenue Growth: 5.74%
Revenue Growth (this year): 8.6% Revenue Growth (next year): 7.10%

Share on Social Networks: